John P. Braselton - Concepedia

Author

John P. Braselton

Pfizer (United States)

Also Known As

J P Braselton, J. BRASELTON, J. Braselton, J. P. BRASELTON, J.P. Braselton, John Braselton, John P. Braselton

Publications

948

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Mead Johnson (United States)

About

John P. Braselton is an author at Pfizer (United States) specializing in pharmacology, medicine, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	801
2	Social Sciences	4	4	540
3	Health Sciences	2	2	49
4	Natural Sciences	1	1	48
5	Biochemistry	1	1	48

John P. Braselton

Publications

925

Citations

H-Index

Page 1

	Year	Citations
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. David W. Schulz, Robert S. Mansbach, Jeffrey Sprouse, Proceedings of the National Academy of Sciences Social SciencesMolecular PharmacologyCrf ReceptorsNeuroimmunologyNeurochemistry	1996	378
8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production Jeffrey Sprouse, Linda Reynolds, Xing‐Fang Li, Neuropharmacology Circadian Rhythm5-Ht7 AgonistSleepCamp ProductionAlertness	2003	137
Fluoxetine Modulates the Circadian Biological Clock via Phase Advances of Suprachiasmatic Nucleus Neuronal Firing Jeffrey Sprouse, John P. Braselton, Linda Reynolds Biological Psychiatry Circadian RhythmAlertnessNeurophysiologyCircadian Biological ClockMedicine	2006	122
2-Aryloxy-4-alkylaminopyridines: Discovery of Novel Corticotropin-Releasing Factor 1 Antagonists Yuhpyng L. Chen, R. Scott Obach, John P. Braselton, Journal of Medicinal Chemistry	2008	69
Synthesis and SAR of 2-Aryloxy-4-alkoxy-pyridines as Potent Orally Active Corticotropin-Releasing Factor 1 Receptor Antagonists Yuhpyng L. Chen, John P. Braselton, James T. Forman, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceBiochemistryMedicineNatural Sciences	2008	48
Serotonin‐induced phase advances of SCN neuronal firing in vitro: A possible role for 5‐HT<sub>5A</sub> receptors? Jeffrey Sprouse, Linda Reynolds, John P. Braselton, Synapse	2004	44
Effects of a potential antipsychotic, BMY 14802, on firing of central serotonergic and noradrenergic neurons in rats Cam P. VanderMaelen, John P. Braselton European Journal of Pharmacology NeuropsychologyPsychoactive DrugPsychiatryNeurophysiologyNeuroanatomy	1990	30
Activation of postsynaptic 5‐HT<sub>1A</sub> receptors by fluoxetine despite the loss of firing‐dependent serotonergic input: Electrophysiological and neurochemical studies Jeffrey Sprouse, John P. Braselton, L S Reynolds, Synapse Synaptic TransmissionNeurotransmitterNeurotransmissionNeurochemistryHealth Sciences	2001	27
5-HT1A agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus Jeffrey Sprouse, John P. Braselton, Linda Reynolds Biological Psychiatry NeurophysiologyMedicineSynaptic TransmissionPhysiologyNeurotransmitter	2000	22
Antifertility activity of some .beta.-amino alcohols Duane F. Morrow, P. C. Johnson, H. Torabi, Journal of Medicinal Chemistry .Beta.-amino AlcoholsMedicinal ChemistryPharmaceutical ScienceDonut IconMedicine	1973	14

Page 1